Metabolomics Coupled with Multivariate Data and Pathway Analysis on Potential Biomarkers in Cholestasis and Intervention Effect of Paeonia lactiflora Pall

被引:46
作者
Ma, Xiao [1 ,2 ]
Chi, Yong-Hui [3 ]
Niu, Ming [4 ]
Zhu, Yun [5 ]
Zhao, Yan-Ling [1 ]
Chen, Zhe [1 ,2 ]
Wang, Jia-Bo [4 ]
Zhang, Cong-En [2 ,4 ]
Li, Jian-Yu [5 ]
Wang, Li-Fu [5 ]
Gong, Man [5 ]
Wei, Shi-Zhang [1 ,2 ]
Chen, Chang [1 ,2 ]
Zhang, Lu [1 ,2 ]
Wu, Ming-Quan [1 ,2 ]
Xiao, Xiao-He [4 ]
机构
[1] 302 Mil Hosp China, Dept Pharm, Beijing, Peoples R China
[2] Chengdu Univ Tradit Chinese Med, Coll Pharm, Chengdu, Peoples R China
[3] Capital Med Univ, Dept Cardiol, Beijing Chao Yang Hosp, Beijing, Peoples R China
[4] 302 Mil Hosp China, China Mil Inst Chinese Med, Beijing, Peoples R China
[5] 302 Mil Hosp China, Dept Integrat Med Ctr, Beijing, Peoples R China
基金
中国国家自然科学基金;
关键词
Paeonia lactiflora Pall; cholestasis; metabolomics; bile acid secretion; biomarker; TRADITIONAL CHINESE MEDICINE; URSODEOXYCHOLIC ACID; LIVER-INJURY; AMINO-ACIDS; PROTECTS; DECOCTION; SEROTONIN; HEPATITIS; MODEL; RAT;
D O I
10.3389/fphar.2016.00014
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background: The dried root of Paeonia lactiflora Pall. (PLP) is a classical Chinese herbal medicine that has been used to treat hepatic disease for 1000s of years. Our previous work suggested that PLP can be used to treat hepatitis with severe cholestasis. This study explored the mechanism by which PLP affects ANIT-induced cholestasis in rats using a metabolomics approach. Methods: The effects of PLP on serum indices (TBIL, DBIL, AST, ALT, ALP, and TBA) and the histopathology of the liver were analyzed. Moreover, UHPLC-Q-TOF was performed to identify the possible effect of PLP on metabolites. The pathway analysis was conducted to illustrate the pathways and network by which PLP treats cholestasis. Result: High-dose PLP remarkably down-regulated the serum indices and alleviated histological damage to the liver. Metabolomics analyses showed that the therapeutic effect of high-dose PLP is mainly associated with the regulation of several metabolites, such as glycocholic acid, taurocholic acid, glycochenodeoxycholic acid, L(D)-arginine, and L-tryptophan. A pathway analysis showed that the metabolites were related to bile acid secretion and amino acid metabolism. In addition, the significant changes in bile acid transporters also indicated that bile acid metabolism might be involved in the therapeutic effect of PLP on cholestasis. Moreover, a principal component analysis indicated that the metabolites in the high-dose PLP group were closer to those of the control, whereas those of the moderate dose or low-dose PLP group were closer to those of the ANIT group. This finding indicated that metabolites may be responsible for the differences between the effects of low-dose and moderate-dose PLP. Conclusion: The therapeutic effect of high-dose PLP on cholestasis is possibly related to regulation of bile acid secretion and amino acid metabolism. Moreover, these findings may help better understand the mechanisms of disease and provide a potential therapy for cholestasis.
引用
收藏
页数:12
相关论文
共 44 条
[1]   Metabolomic investigation of cholestasis in a rat model using ultra-performance liquid chromatography/tandem mass spectrometry [J].
Aoki, Masayo ;
Konya, Yutaka ;
Takagaki, Takeshi ;
Umemura, Koji ;
Sogame, Yoshihisa ;
Katsumata, Takashi ;
Komuro, Setsuko .
RAPID COMMUNICATIONS IN MASS SPECTROMETRY, 2011, 25 (13) :1847-1852
[2]   Combination of ursodeoxycholic acid and glucocorticoids upregulates the AE2 alternate promoter in human liver cells [J].
Arenas, Fabian ;
Hervias, Isabel ;
Uriz, Miriam ;
Joplin, Ruth ;
Prieto, Jesus ;
Medina, Juan F. .
JOURNAL OF CLINICAL INVESTIGATION, 2008, 118 (02) :695-709
[3]   New paradigms in the treatment of hepatic cholestasis: From UDCA to FXR, PXR and beyond [J].
Beuers, Ulrich ;
Trauner, Michael ;
Jansen, Peter ;
Poupon, Raoul .
JOURNAL OF HEPATOLOGY, 2015, 62 :S25-S37
[4]   The metabolomic window into hepatobiliary disease [J].
Beyoglu, Diren ;
Idle, Jeffrey R. .
JOURNAL OF HEPATOLOGY, 2013, 59 (04) :842-858
[5]   Liver protective effect of ursodeoxycholic acid includes regulation of ADAM17 activity [J].
Buryova, Halka ;
Chalupsky, Karel ;
Zbodakova, Olga ;
Kanchev, Ivan ;
Jirouskova, Marketa ;
Gregor, Martin ;
Sedlacek, Radislav .
BMC GASTROENTEROLOGY, 2013, 13
[6]   The application of metabolomics in traditional Chinese medicine opens up a dialogue between Chinese and Western medicine [J].
Cao, Hongxin ;
Zhang, Aihua ;
Zhang, Huamin ;
Sun, Hui ;
Wang, Xijun .
PHYTOTHERAPY RESEARCH, 2015, 29 (02) :159-166
[7]   Adaptive responses of renal organic anion transporter 3 (OAT3) during cholestasis [J].
Chen, Jiarong ;
Terada, Tomohiro ;
Ogasawara, Ken ;
Katsura, Toshiya ;
Inui, Ken-ichi .
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2008, 295 (01) :F247-F252
[8]   Paeoniflorin protects against concanavalin A-induced hepatitis in mice [J].
Chen, Mingsheng ;
Cao, Lijun ;
Luo, Yijun ;
Feng, Xiaofeng ;
Sun, Lu ;
Wen, Min ;
Peng, Shaobin .
INTERNATIONAL IMMUNOPHARMACOLOGY, 2015, 24 (01) :42-49
[9]   Yinchenhao decoction in the treatment of cholestasis: A systematic review and meta-analysis [J].
Chen, Zhe ;
Ma, Xiao ;
Zhao, Yanling ;
Wang, Jiabo ;
Zhang, Yaming ;
Li, Jianyu ;
Wang, Ruilin ;
Zhu, Yun ;
Wang, Lifu ;
Xiao, Xiaohe .
JOURNAL OF ETHNOPHARMACOLOGY, 2015, 168 :208-216
[10]   Systemic Causes of Cholestasis [J].
deLemos, Andrew S. ;
Friedman, Lawrence S. .
CLINICS IN LIVER DISEASE, 2013, 17 (02) :301-+